HRA000494
Title:
Genomic profiling identified novel prognostic biomarkers in Chinese midline glioma patients
Release date:
2020-12-16
Description:
In this study, we aim to explore the genomic makeup of midline glioma patients and to fill the gaps in the prognostic heterogeneity through comprehensive genetic and oncogenic pathways analyses. As mainstay treatment of glioma remained to be surgery resection, radiotherapy, and chemotherapy, we also hope to provide fresh insights into further subgroup stratification in midline glioma patients.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cohort Study
Disease name:
brain glioma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Glioma Data Management
Contact person:
Zhang Xian
Email:
472116921@qq.com
Description:
This committee controls and manages DNA sequencing data of human midline glioma patient samples used in this study.
Individuals & samples
Submitter:   Li Zhi / lizhi20203939@163.com
Organization:   Guangdong Provincial People's Hospital
Submission date:   2020-12-02
Requests:   -